Followers | 131 |
Posts | 29747 |
Boards Moderated | 0 |
Alias Born | 12/21/2008 |
Saturday, July 07, 2012 9:49:30 AM
It's very different when you are on the inside looking out than when you are on the outside looking in, he said.
Since winning a proxy fight for control on Aug. 31, Portnoy and his brother, Mark, co-CEO, have revamped the way Cryo-Cell (OTCQB: CCEL), a stem cell preservation company in Oldsmar, connects with customers and business partners, strengthening B2B relationships, as detailed in Friday's story in the Tampa Bay Business Journal.
Their own thinking also has undergone a transformation over the past six months.
"At first, we were just investors," said Mark Portnoy, recalling how he and his brother had watched the stock market from a very early age. But now that they are running Cryo-Cell and have become immersed in the science and medical potential of stem cells, "it feels good to do good," he said.
They've learned that stem cell transplants are known and accepted treatments for more than 80 diseases. They've come to appreciate the value of an initiative Cryo-Cell launched in 2007, to preserve menstrual stem cells which are being studied as potential treatments for diabetes, breast cancer, heart disease, stroke and autoimmune diseases. David Portnoy now sees Cryo-Cell as a company at the forefront of regenerative medicine.
They've still got some convincing to do for other investors. Cryo-Cell's stock price closed at $2.90 a share on Aug. 31, the day the results of the proxy fight were announced, and has since dropped to as low as $1.57 a share. The stock closed Thursday at $2.24.
Margie Manning is Quality and Content Editor of the Tampa Bay Business Journal. She also covers banking, finance and professional services.
My attitude with penny stocks is similar to Vegas - I don't use any funds I'm not prepared to totally lose.
Not to say I don't try very hard to "win", but it minimizes the stress of sudden movements.
Recent CCEL News
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results • Business Wire • 04/15/2024 09:00:00 PM
- Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value • Business Wire • 03/25/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 10:20:13 PM
- Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023 • Business Wire • 02/28/2024 10:00:00 PM
- Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET • GlobeNewswire Inc. • 01/22/2024 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 10:00:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/12/2023 09:01:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 09:00:21 PM
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results • Business Wire • 10/12/2023 08:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 08:30:34 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 09/15/2023 03:30:08 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/14/2023 08:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/25/2023 08:17:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/14/2023 09:11:16 PM
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results • Business Wire • 07/14/2023 08:15:00 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM